Holen Sie sich die Stockscreener-App
1.95
1.02%
-0.02
Aclaris Therapeutics Inc Aktie (ACRS) Neueste Nachrichten
Strategies to average down on Aclaris Therapeutics Inc.Short Setup & Daily Technical Forecast Reports - newser.com
Aclaris Therapeutics Inc.’s volatility index tracking explainedShare Buyback & Stock Portfolio Risk Management - newser.com
Jacobs Levy Equity Management Inc. Has $705,000 Position in Aclaris Therapeutics, Inc. $ACRS - Defense World
OMERS ADMINISTRATION Corp Grows Stake in Aclaris Therapeutics, Inc. $ACRS - MarketBeat
Aclaris to present additional data on atopic dermatitis drug at EADV - Investing.com Canada
Aclaris to present additional data on atopic dermatitis drug at EADV By Investing.com - Investing.com South Africa
Aclaris Therapeutics Announces Late-Breaking Abstract and - GlobeNewswire
Aclaris Therapeutics Announces Late-Breaking Abstract on Phase 2a Trial Results of ATI-2138 for Atopic Dermatitis at EADV Congress 2025 - Quiver Quantitative
Phase 2a Results: Aclaris' Novel ITK/JAK3 Inhibitor for Atopic Dermatitis at Major Dermatology Congress - Stock Titan
Can Aclaris Therapeutics Inc. deliver consistent dividendsJuly 2025 Levels & Precise Entry and Exit Recommendations - beatles.ru
Aclaris Therapeutics, Inc. $ACRS Shares Sold by Walleye Capital LLC - MarketBeat
Palo Alto Investors LP Buys 206,196 Shares of Aclaris Therapeutics, Inc. $ACRS - MarketBeat
What’s the recovery path for long term holders of Aclaris Therapeutics Inc.Quarterly Earnings Report & High Conviction Buy Zone Alerts - Newser
Will Aclaris Therapeutics Inc. benefit from rising consumer demandJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
Visual analytics tools that track Aclaris Therapeutics Inc. performanceQuarterly Trade Review & High Accuracy Trade Alerts - Newser
Will Aclaris Therapeutics Inc. outperform the market in YEARMarket Activity Recap & Short-Term Swing Trade Alerts - خودرو بانک
What’s the outlook for Aclaris Therapeutics Inc.’s sectorMarket Sentiment Summary & Weekly Watchlist for Hot Stocks - خودرو بانک
Aclaris Therapeutics to Present at Two Investor Conferences in September - MSN
Is Aclaris Therapeutics Inc.’s ROE strong enough2025 Short Interest & Entry and Exit Point Strategies - خودرو بانک
Is Aclaris Therapeutics Inc. likely to announce a buybackQuarterly Performance Summary & Weekly Top Stock Performers List - خودرو بانک
Will Aclaris Therapeutics Inc. face regulatory challenges2025 Short Interest & Weekly Breakout Stock Alerts - خودرو بانک
Can technical indicators confirm Aclaris Therapeutics Inc.’s reversalBear Alert & Low Risk High Win Rate Stock Picks - Newser
Aclaris Therapeutics Inc. recovery potential after sell off2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Aclaris Therapeutics Inc. stock outlook for YEARWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Can Aclaris Therapeutics Inc. continue delivering strong returnsJuly 2025 Spike Watch & Long-Term Growth Plans - خودرو بانک
Aclaris Therapeutics Inc. stock momentum explainedJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - Newser
How sentiment analysis helps forecast Aclaris Therapeutics Inc.Market Movement Recap & Technical Confirmation Alerts - Newser
Can Aclaris Therapeutics Inc. recover in the next quarterMarket Performance Summary & AI Driven Price Forecasts - Newser
Market reaction to Aclaris Therapeutics Inc.’s recent news2025 Bull vs Bear & Smart Money Movement Tracker - Newser
Will Aclaris Therapeutics Inc. continue its uptrendPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
What’s the MACD signal for Aclaris Therapeutics Inc.2025 Valuation Update & Daily Profit Maximizing Trade Tips - خودرو بانک
How to escape a deep drawdown in Aclaris Therapeutics Inc.2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Is Aclaris Therapeutics Inc. stock ready for a breakoutGap Up & Free Technical Confirmation Trade Alerts - Newser
Aclaris at Cantor Global Healthcare: Strategic Pipeline Insights - Investing.com
Forecasting Aclaris Therapeutics Inc. price range with options dataTrade Entry Report & Reliable Price Action Trade Plans - Newser
Using data tools to time your Aclaris Therapeutics Inc. exitJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
Volatility clustering patterns for Aclaris Therapeutics Inc.2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Real time pattern detection on Aclaris Therapeutics Inc. stock2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
Long term hold vs stop loss in Aclaris Therapeutics Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Aclaris Therapeutics Inc. stock trendline breakdown2025 Winners & Losers & Verified Technical Signals - Newser
Earnings visualization tools for Aclaris Therapeutics Inc.2025 Institutional Moves & Weekly High Potential Alerts - Newser
Is Aclaris Therapeutics Inc. a speculative investmentStop Loss & Weekly High Conviction Trade Ideas - خودرو بانک
What’s the beta of Aclaris Therapeutics Inc. stockPortfolio Update Report & Verified Short-Term Plans - خودرو بانک
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer - MSN
Developing predictive dashboards with Aclaris Therapeutics Inc. dataJuly 2025 Levels & Real-Time Buy Signal Alerts - Newser
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):